Coyle Financial Counsel’s Pfizer PFE Stock Holding History

Coyle Financial Counsel’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-6,296	Closed	-$217K	–	228
2018 Q2	$217K	Buy	6,296 +5,686	+932%	+$194K	0.2%	46
2018 Q1	$21K	Buy	+610	New	+$21K	0.02%	70

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Coyle Financial Counsel's PFE Position: Q3 2018 in Review

Coyle Financial Counsel sold out of Pfizer (PFE) in Q3 2018, closing a stake of 6,296 shares — an estimated $217K sold.

Coyle Financial Counsel first reported a position in PFE in Q1 2018 and held it in 2 quarters. The position peaked at $217K in Q2 2018. 2,256 funds tracked by Wall St. Rank hold PFE as of Q3 2018.

Coyle Financial Counsel reported no remaining Pfizer position as of Q3 2018 after selling out during the quarter.
Coyle Financial Counsel sold 6,296 Pfizer shares in Q3 2018, an estimated $217K.
Coyle Financial Counsel first reported a position in Pfizer in Q1 2018 and held it in 2 quarters.
Coyle Financial Counsel's Pfizer position peaked at $217K in Q2 2018.
2,256 funds tracked by Wall St. Rank held Pfizer as of Q3 2018.

Based on Coyle Financial Counsel's 13F filing for Q3 2018, filed 13 Nov 2018.